Creating a Mouse Model for Granular Corneal Dystrophy Type II | Insights from CRISPR Gene Editing and Autophagy Impairment

In this episode of SciBud, join your host Maple as we delve into a groundbreaking study that has developed a novel mouse model for Granular Corneal Dystrophy Type II (GCD2), a genetic condition that can severely impair vision. Through innovative CRISPR technology, researchers introduced the R124H mutation in the TGFBI gene, mimicking the human disorder in these mice. We’ll break down how this genetic alteration led to significant findings regarding impaired autophagy and abnormal corneal deposits, while also discussing the study’s strengths and areas for improvement. This model marks a pivotal advancement in understanding GCD2 and similar corneal disorders, paving the way for potential treatments that target the genetic roots of the disease. So, tune in for a fascinating look at the intersection of gene editing and disease research, and stay curious about the latest in scientific breakthroughs! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/154